Mectizan Donation Program | Local power. Global Change.
MERCK A program at The Task Force for Global Health
Switch to French site

Where We Work

The Mectizan® Donation Program (MDP) provided ivermectin for mass drug administration (MDA) in 28 countries in 2017. With the expansion of MDP by providing Mectizan for triple therapy to eliminate LF, another 42 countries may be eligible to receive the drug starting in 2018.

Status of MDA in Onchocerciasis Endemic Countries in 2017

Status of MDA in Lymphatic Filariasis Endemic Countries in 2017

*Countries in bold are countries that may be eligible to receive Mectizan as part of triple therapy to eliminate LF.

Milestones

Established in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* The Mectizan® Donation Program ...

The Diseases

The Mectizan® Donation Program (MDP or the Program) is an international program working to eliminate ...

Where We Work

The Mectizan® Donation Program (MDP) provided ivermectin for mass drug administration (MDA) in 28 countries ...

The Medicines

Mectizan® (ivermectin)—donated by Merck & Co., Inc., Kenilworth, N.J., U.S.A.*—was the first drug donated for ...

History of the program

For centuries, river blindness (also known as onchocerciasis) plagued remote communities in Africa, Latin America, ...

Overview

Established in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* the Mectizan Donation Program ...